Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.

A Carlson, L; Rosenhamer, G

doi:10.1111/j.0954-6820.1988.tb15891.x

Public

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.

Shared by NobleBlocks on Jan 1, 1988 • 12:00 AM UTC

Authors:

L A Carlson

G Rosenhamer

Abstract

Consecutive survivors of a myocardial infarction from the Southern Hospital, below 70 years of age, were randomized into a Control group (n = 276) and a Treatment group (n = 279). The latter was openly prescribed the combination of clofibrate and nicotinic acid for serum lipid lowering. Each patient...

Discussions